REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38,210,377 | -46.2% | 1,604,130 | -55.5% | 29.95% | -3.5% |
| Q3 2022 | $71,073,000 | -28.6% | 3,604,130 | -29.4% | 31.03% | -23.7% |
| Q2 2022 | $99,479,000 | -29.4% | 5,104,130 | -7.6% | 40.69% | +6.4% |
| Q1 2022 | $140,918,000 | +1.4% | 5,524,031 | 0.0% | 38.24% | +9.9% |
| Q4 2021 | $139,040,000 | -8.5% | 5,524,031 | 0.0% | 34.79% | +20.6% |
| Q3 2021 | $151,966,000 | -13.3% | 5,524,031 | 0.0% | 28.85% | -5.8% |
| Q2 2021 | $175,333,000 | -30.8% | 5,524,031 | 0.0% | 30.61% | -4.5% |
| Q1 2021 | $253,443,000 | -8.9% | 5,524,031 | -21.4% | 32.06% | +34.2% |
| Q4 2020 | $278,081,000 | -0.4% | 7,024,031 | -12.5% | 23.88% | +1.8% |
| Q3 2020 | $279,236,000 | -2.0% | 8,024,031 | -11.1% | 23.46% | -43.6% |
| Q2 2020 | $284,889,000 | +44.1% | 9,024,031 | 0.0% | 41.58% | -22.7% |
| Q1 2020 | $197,717,000 | – | 9,024,031 | – | 53.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |